Delivery Order SPE2DB24D2012-SPE2DB24FBUMV
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $8.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $7,194.78 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 MCG inhaler 12GM. The contract has a completion date of February 26, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564221188 Advair HFA 115-21 mcg Inhaler 12 gm to the agency. The $2,295.58 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and also holds an indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhaler, a specialty pharmaceutical product. The $2,099.79 contract has a completion date of February 14, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of the company's...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $4,157.81 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4,564,176,771 Advair HFA 115-21 MCG Inhaler 12GM medical devices. This award is under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds as the prime contractor,...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 230-21 MCG Inhaler, a brand name pharmaceutical product. The delivery order, valued at $6,889.47, has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with a larger contract vehicle. No...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D2101|SPE2DX24F50ZS) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 115-21 mcg inhalers. The $7,583.58 delivery order has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to deliver...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,029,522 units of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The award, with a ceiling value of $1,422.58, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates under an indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,240 units of the prescription drug Advair HFA 230-21 MCG Inhaler 12GM. The contract has a completion date of February 6, 2024 and a potential value of $6,901.94. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. This...
- The Defense Logistics Agency (DLA) awarded a $4,866.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,248,106 units of the Advair HFA 115-21 MCG inhaler (12 gram). This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at up to $999,999,999.00 and effective through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,183.32 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Advair HFA 230-21 mcg inhalers to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB24FBUMVDelivery Order
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,029,867 units of the Advair HFA 115-21 mcg inhaler (12 gm) with a ceiling value of $8,785.49. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This award does not have a set-aside designation.
Generated 6/19/24, 9:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 3/20/24 |